Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist (RHUMPSO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04800289
Recruitment Status : Recruiting
First Posted : March 16, 2021
Last Update Posted : March 16, 2021
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier le Mans

Brief Summary:
Current increase in the number of multidisciplinary consultations, but little documentation on their impact on patient management. More specifically, in the context of psoriatic arthritis, we are seeking to investigate the interest for the patient, through his or her satisfaction and the evolution of the activity of his or her pathology, of a global, joint management in Rheumatology and Dermatology.

Condition or disease Intervention/treatment
Psoriatic Arthritis Other: questionnaires

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 600 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist
Actual Study Start Date : July 19, 2020
Estimated Primary Completion Date : July 31, 2030
Estimated Study Completion Date : July 31, 2030

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: questionnaires
    questionnaires about disease and satisfaction of patient


Primary Outcome Measures :
  1. impact on patient satisfaction and the evolution of their pathology of these mixed consultations, Dermatologist and Rheumatologist, in the context of psoriatic arthritis. [ Time Frame: 5 years after inclusion ]
    evaluate the impact on patient satisfaction and the evolution of their pathology of these mixed consultations, Dermatologist and Rheumatologist, in the context of psoriatic arthritis.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients received in a joint rheumatologist/dermatologist consultation at the Le Mans Hospital
Criteria

Inclusion Criteria:

  • All patients received in a joint rheumatologist/dermatologist consultation at the Le Mans Hospital

Exclusion Criteria:

  • Diagnosis of psoriatic arthritis not retained

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04800289


Contacts
Layout table for location contacts
Contact: Christelle JADEAU 02 43 43 43 43 cjadeau@ch-lemans.fr
Contact: Emmanuelle DERNIS 02 43 43 43 43 edernis@ch-lemans.fr

Locations
Layout table for location information
France
Centre Hospitalier Du Mans Recruiting
Le Mans, France, 72000
Contact: Christelle JADEAU    02 44 71 07 81    cjadeau@ch-lemans.fr   
Sponsors and Collaborators
Centre Hospitalier le Mans
Layout table for additonal information
Responsible Party: Centre Hospitalier le Mans
ClinicalTrials.gov Identifier: NCT04800289    
Other Study ID Numbers: CHM-2019/S7/11
First Posted: March 16, 2021    Key Record Dates
Last Update Posted: March 16, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Arthritis, Psoriatic
Arthritis
Joint Diseases
Musculoskeletal Diseases
Spondylarthropathies
Spondylarthritis
Spondylitis
Spinal Diseases
Bone Diseases
Psoriasis
Skin Diseases, Papulosquamous
Skin Diseases